Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 22084326)

1.

Adolescent vaccination-coverage levels in the United States: 2006-2009.

Stokley S, Cohn A, Dorell C, Hariri S, Yankey D, Messonnier N, Wortley PM.

Pediatrics. 2011 Dec;128(6):1078-86. doi: 10.1542/peds.2011-1048. Epub 2011 Nov 14.

2.

Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009.

Dorell C, Yankey D, Strasser S.

Clin Pediatr (Phila). 2011 Dec;50(12):1116-24. doi: 10.1177/0009922811415104. Epub 2011 Aug 19.

PMID:
21856964
3.

Middle school vaccination requirements and adolescent vaccination coverage.

Bugenske E, Stokley S, Kennedy A, Dorell C.

Pediatrics. 2012 Jun;129(6):1056-63. doi: 10.1542/peds.2011-2641. Epub 2012 May 7.

4.

National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Aug 30;62(34):685-93.

5.

National and state vaccination coverage among adolescents aged 13 through 17 years--United States, 2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Aug 26;60(33):1117-23.

6.

National and state vaccination coverage among adolescents aged 13-17 years--United States, 2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Aug 31;61(34):671-7. Erratum in: MMWR Morb Mortal Wkly Rep. 2012 Oct 19;61(41):844.

7.

Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP).

Broder KR, Cortese MM, Iskander JK, Kretsinger K, Slade BA, Brown KH, Mijalski CM, Tiwari T, Weston EJ, Cohn AC, Srivastava PU, Moran JS, Schwartz B, Murphy TV; Advisory Committee on Immunization Practices (ACIP).

MMWR Recomm Rep. 2006 Mar 24;55(RR-3):1-34.

8.

National vaccination coverage among adolescents aged 13-17 years--United States, 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Aug 31;56(34):885-8.

9.

National, state, and local area vaccination coverage among adolescents aged 13-17 years --- United States, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Aug 20;59(32):1018-23.

10.

Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

America Academy of Pediatrics Commitee on Infectious Diseases.

Pediatrics. 2006 Mar;117(3):965-78. Epub 2005 Dec 28.

PMID:
16382131
11.

Compliance with recommendations and opportunities for vaccination at ages 11 to 12 years: evaluation of the 2009 national immunization survey-teen.

Stokley S, Cohn A, Jain N, McCauley MM.

Arch Pediatr Adolesc Med. 2011 Sep;165(9):813-8. doi: 10.1001/archpediatrics.2011.138.

PMID:
21893647
12.

National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years--United States, 2013.

Elam-Evans LD, Yankey D, Jeyarajah J, Singleton JA, Curtis RC, MacNeil J, Hariri S; Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Jul 25;63(29):625-33.

13.

Vaccination coverage among adolescents aged 13-17 years - United States, 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3. Erratum in: MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):10.

14.

Adolescent vaccine co-administration and coverage in New York City: 2007-2013.

Sull M, Eavey J, Papadouka V, Mandell R, Hansen MA, Zucker JR.

Pediatrics. 2014 Dec;134(6):e1576-83. doi: 10.1542/peds.2014-1452. Epub 2014 Nov 10.

PMID:
25384490
15.

Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 15;59(40):1302-6.

16.

Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.

Arguedas A, Soley C, Loaiza C, Rincon G, Guevara S, Perez A, Porras W, Alvarado O, Aguilar L, Abdelnour A, Grunwald U, Bedell L, Anemona A, Dull PM.

Vaccine. 2010 Apr 19;28(18):3171-9. doi: 10.1016/j.vaccine.2010.02.045. Epub 2010 Feb 26.

PMID:
20189491
17.

Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010.

Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, Jacobson RM.

Pediatrics. 2013 Apr;131(4):645-51. doi: 10.1542/peds.2012-2384. Epub 2013 Mar 18.

18.

A population-level assessment of factors associated with uptake of adolescent-targeted vaccines in Michigan.

Gowda C, Dong S, Potter RC, Dombkowski KJ, Dempsey AF.

J Adolesc Health. 2013 Oct;53(4):498-505. doi: 10.1016/j.jadohealth.2013.07.022.

PMID:
24054080
19.
20.

Human papillomavirus vaccination series initiation and completion, 2008-2009.

Dorell CG, Yankey D, Santibanez TA, Markowitz LE.

Pediatrics. 2011 Nov;128(5):830-9. doi: 10.1542/peds.2011-0950. Epub 2011 Oct 17. Erratum in: Pediatrics. 2012 Jul;130(1):166-8. Dosage error in article text.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk